Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antitumor activity of interleukin-12

M J Brunda1, M K Gately

  • 1Department of Oncology, Hoffmann-La Roche Inc., Nutley, New Jersey 07110.

Clinical Immunology and Immunopathology
|June 1, 1994
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Complete regression of established spontaneous mammary carcinoma and the therapeutic prevention of genetically programmed neoplastic transition by IL-12/pulse IL-2: induction of local T cell infiltration, Fas/Fas ligand gene expression, and mammary epithelial apoptosis.

Journal of immunology (Baltimore, Md. : 1950)·2001
Same author

Peginterferon alfa-2a in patients with chronic hepatitis C.

The New England journal of medicine·2000
Same author

In vitro and in vivo responses to interleukin 12 are maintained until the late SIV infection stage but lost during AIDS.

AIDS research and human retroviruses·2000
Same author

Down-regulation of the pharmacokinetic-pharmacodynamic response to interleukin-12 during long-term administration to patients with renal cell carcinoma and evaluation of the mechanism of this "adaptive response" in mice.

Clinical pharmacology and therapeutics·1999
Same author

IL-12 is dispensable for innate and adaptive immunity against low doses of Listeria monocytogenes.

International immunology·1999
Same author

Recruitment of hepatic NK cells by IL-12 is dependent on IFN-gamma and VCAM-1 and is rapidly down-regulated by a mechanism involving T cells and expression of Fas.

Journal of immunology (Baltimore, Md. : 1950)·1998